Article
Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis
16 Apr 2021
Abstract excerpt
Background Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer. At present, most patients with LUAD are diagnosed at an advanced stage, and the prognosis of advanced LUAD is poor. Hence, we aimed to identify novel biomarkers for the diagnosis and treatment of early stage LUAD and to explore their predictive value. Methods The microarray datasets GSE63459, GSE27262, and GSE33532 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
